These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

304 related items for PubMed ID: 12194790

  • 1. [Prognosis of non-small cell lung cancer patients with microscopic residual disease at bronchial stump after lung resection].
    Dai W, Yu C, Sun Y.
    Zhonghua Yi Xue Za Zhi; 2002 Aug 10; 82(15):1022-4. PubMed ID: 12194790
    [Abstract] [Full Text] [Related]

  • 2. Survival according to the site of bronchial microscopic residual disease after lung resection for non-small cell lung cancer.
    Collaud S, Bongiovanni M, Pache JC, Fioretta G, Robert JH.
    J Thorac Cardiovasc Surg; 2009 Mar 10; 137(3):622-6. PubMed ID: 19258078
    [Abstract] [Full Text] [Related]

  • 3. Residual disease at the bronchial stump after curative resection for lung cancer.
    Wind J, Smit EJ, Senan S, Eerenberg JP.
    Eur J Cardiothorac Surg; 2007 Jul 10; 32(1):29-34. PubMed ID: 17466532
    [Abstract] [Full Text] [Related]

  • 4. Morbidity, mortality, and long-term survival after sleeve lobectomy for non-small cell lung cancer.
    Yildizeli B, Fadel E, Mussot S, Fabre D, Chataigner O, Dartevelle PG.
    Eur J Cardiothorac Surg; 2007 Jan 10; 31(1):95-102. PubMed ID: 17126556
    [Abstract] [Full Text] [Related]

  • 5. [Prognosis after complete surgical resection for non-small cell lung cancer based on the staging classification].
    Pfannschmidt J, Muley T, Hoffmann H, Bülzebruck H, Dienemann H.
    Dtsch Med Wochenschr; 2006 Nov 24; 131(47):2643-8. PubMed ID: 17109272
    [Abstract] [Full Text] [Related]

  • 6. Importance of microscopic residual disease at the bronchial margin after resection for non-small-cell carcinoma of the lung.
    Liewald F, Hatz RA, Dienemann H, Sunder-Plassmann L.
    J Thorac Cardiovasc Surg; 1992 Aug 24; 104(2):408-12. PubMed ID: 1323002
    [Abstract] [Full Text] [Related]

  • 7. Concurrent cisplatin/etoposide plus 3D-conformal radiotherapy followed by surgery for stage IIB (superior sulcus T3N0)/III non-small cell lung cancer yields a high rate of pathological complete response.
    Pourel N, Santelmo N, Naafa N, Serre A, Hilgers W, Mineur L, Molinari N, Reboul F.
    Eur J Cardiothorac Surg; 2008 May 24; 33(5):829-36. PubMed ID: 18367406
    [Abstract] [Full Text] [Related]

  • 8. [Extent of lymphadenectomy in stage I-IIIA non-small cell lung cancer: a randomized clinical trial].
    Wu Y, Wang S, Huang Z.
    Zhonghua Zhong Liu Za Zhi; 2001 Jan 24; 23(1):43-5. PubMed ID: 11783068
    [Abstract] [Full Text] [Related]

  • 9. Bronchial resection margin length and clinical outcome in non-small cell lung cancer.
    Tomaszek SC, Kim Y, Cassivi SD, Jensen MR, Shen KH, Nichols FC, Deschamps C, Wigle DA.
    Eur J Cardiothorac Surg; 2011 Nov 24; 40(5):1151-6. PubMed ID: 21450488
    [Abstract] [Full Text] [Related]

  • 10. [The study of peri-operative chemotherapy in stage I-IIIa NSCLC].
    Liao ML, Zhou YZ, Ding JA, Ni GX, Zhao JM, Chen WH, Han BH, Shen J, Bai H, Chen ZW, Ji H, Wang HM, Zhou Z.
    Zhonghua Yi Xue Za Zhi; 2003 Jun 10; 83(11):962-6. PubMed ID: 12899797
    [Abstract] [Full Text] [Related]

  • 11. The side of pneumonectomy influences long-term survival in stage I and II non-small cell lung cancer.
    Simón C, Moreno N, Peñalver R, González G, Alvarez-Fernández E, González-Aragoneses F, Bronchogenic Carcinoma Cooperative Group of the Spanish Society of Pneumology and Thoracic Surgery.
    Ann Thorac Surg; 2007 Sep 10; 84(3):952-8. PubMed ID: 17720406
    [Abstract] [Full Text] [Related]

  • 12. Characteristics and prognosis of resected T3 non-small cell lung cancer.
    Ilhan M, Demir A, Akin H, Zek Gunluoglu M, Olçmen A, Dncer SI.
    Minerva Chir; 2008 Apr 10; 63(2):101-8. PubMed ID: 18427442
    [Abstract] [Full Text] [Related]

  • 13. Comparison of morbidity, 30-day mortality, and long-term survival after pneumonectomy and sleeve lobectomy for non-small cell lung carcinoma.
    Ludwig C, Stoelben E, Olschewski M, Hasse J.
    Ann Thorac Surg; 2005 Mar 10; 79(3):968-73. PubMed ID: 15734415
    [Abstract] [Full Text] [Related]

  • 14. [Validity and controversies in the new postoperative pathologic TNM classification based on the results of surgical treatment of non-small cell lung cancer].
    Hosokawa Y, Matsuge S, Murakami Y, Satoh K, Yamazaki S, Kan T, Hatakeyama H.
    Kyobu Geka; 2000 Oct 10; 53(11):910-4. PubMed ID: 11048440
    [Abstract] [Full Text] [Related]

  • 15. Outcomes of sublobar resection versus lobectomy for stage I non-small cell lung cancer: a 13-year analysis.
    El-Sherif A, Gooding WE, Santos R, Pettiford B, Ferson PF, Fernando HC, Urda SJ, Luketich JD, Landreneau RJ.
    Ann Thorac Surg; 2006 Aug 10; 82(2):408-15; discussion 415-6. PubMed ID: 16863738
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Microscopic residual disease after resection for lung cancer: a multifaceted but poor factor of prognosis.
    Riquet M, Achour K, Foucault C, Le Pimpec Barthes F, Dujon A, Cazes A.
    Ann Thorac Surg; 2010 Mar 10; 89(3):870-5. PubMed ID: 20172145
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.